RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT04014790 · COMPLETED

Trial details

NCT number: NCT04014790
Sponsor: Regimmune Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Vs Host Disease Graft-versus-host-disease Acute-graft-versus-host Disease Prevention of aGVHD

Start date: 2019-11-25
Primary completion: 2022-07-05
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.